Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Basel Ramlawi

Thoracic Surgery (Cardiothoracic Vascular Surgery) Wynnewood, PA Medical Doctor

NPI 1265692479 CMS profile 239282

100 E Lancaster Ave Ste 356, Wynnewood, PA 19096

Open in the dashboard

General payments

$1,074,587

1,558 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,300,918 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Basel Ramlawi of Wynnewood, PA is reported in the CMS Open Payments database as having received $1,074,587 across 1,558 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,300,918 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $268,973 342
2024 General $223,895 270
2023 General $230,952 329
2022 General $56,198 159
2021 General $68,262 121
2020 General $84,658 102
2019 General $141,649 235

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Basel Ramlawi
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Basel Ramlawi were reported at $268,973. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Basel Ramlawi Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $141,649 $886 $178–$3,167 $163
2020 $84,658 $341 $108–$1,605 $114
2021 $68,262 $453 $125–$1,886 $132
2022 $56,198 $695 $180–$2,566 $149
2023 $230,952 $745 $205–$2,662 $160
2024 $223,895 $799 $214–$2,967 $164
2025 $268,973 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $639,797 827 payments
  2. Medtronic Vascular, Inc. $138,038 193 payments
  3. LivaNova USA, Inc. $83,340 87 payments
  4. Corcym Inc $82,249 75 payments
  5. Shockwave Medical, Inc $46,633 14 payments
  6. Boston Scientific Corporation $34,306 75 payments
  7. CryoLife, Inc. $23,892 28 payments
  8. Abbott Laboratories $8,789 83 payments
  9. Edwards Lifesciences Corporation $5,757 35 payments
  10. Atricure, Inc. $4,479 41 payments
  11. Other $7,306 100 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $560,108 171 payments
  2. Travel and Lodging $287,870 586 payments
  3. Consulting Fee $159,455 42 payments
  4. Food and Beverage $53,183 753 payments
  5. Honoraria $11,500 2 payments
  6. Grant $2,190 3 payments
  7. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $354,626 515 payments
  2. CoreValve Evolut Transcatheter Valve Systems $113,387 144 payments
  3. Perceval Cardiology/Vascular Diseases $83,246 85 payments
  4. PERCEVAL Pericardial Surgical Heart Valve $82,230 74 payments
  5. CoreValve Evolut Transcatheter Valve Systems $57,479 75 payments
  6. APOLLOTM $56,328 66 payments
  7. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $44,008 12 payments
  8. AMDS-Ascyrus Medical $22,582 21 payments
  9. Avalus $11,120 25 payments
  10. Cardioblate $8,558 42 payments
  11. Other $70,348 342 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$183,819

Medicare's payments for the services billed

Medicare patients

262

Average age 78

Services billed

550

109 women, 153 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Arthritis 51%
Heart failure 50%
Atrial fibrillation 43%
Chronic kidney disease 35%
Diabetes 30%
Cancer 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,558 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record